Structure-Based Design of Novel Alkynyl Thio-Benzoxazepinone Receptor-Interacting Protein Kinase-1 Inhibitors: Extending the Chemical Space from the Allosteric to ATP Binding Pockets
出版年份 2023 全文链接
标题
Structure-Based Design of Novel Alkynyl Thio-Benzoxazepinone Receptor-Interacting Protein Kinase-1 Inhibitors: Extending the Chemical Space from the Allosteric to ATP Binding Pockets
作者
关键词
-
出版物
Journal of Medicinal Chemistry
Volume -, Issue -, Pages -
出版商
American Chemical Society (ACS)
发表日期
2023-02-02
DOI
10.1021/acs.jmedchem.2c02067
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Targeting Necroptosis as a Promising Therapy for Alzheimer’s Disease
- (2022) Wenli Zhao et al. ACS Chemical Neuroscience
- Investigation on the chemical space of the substituted triazole thio-benzoxazepinone RIPK1 inhibitors
- (2022) Yanan Hao et al. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
- The regulation of necroptosis by ubiquitylation
- (2022) Yiliang Chen et al. APOPTOSIS
- Structure-based optimizations of a necroptosis inhibitor (SZM594) as novel protective agents of acute lung injury
- (2021) Lijuan Xu et al. CHINESE CHEMICAL LETTERS
- Structure-based bioisosterism design of thio-benzoxazepinones as novel necroptosis inhibitors
- (2021) Chunnian Xia et al. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
- Necroptosis: A Novel Pathway in Neuroinflammation
- (2021) Ziyu Yu et al. Frontiers in Pharmacology
- Discovery of a cooperative mode of inhibiting RIPK1 kinase
- (2021) Huyan Meng et al. Cell Discovery
- Potent and Selective RIPK1 Inhibitors Targeting Dual‐Pockets for the Treatment of Systemic Inflammatory Response Syndrome and Sepsis
- (2021) Xiangbo Yang et al. ANGEWANDTE CHEMIE-INTERNATIONAL EDITION
- Ligand-based substituent-anchoring design of selective receptor-interacting protein kinase 1 necroptosis inhibitors for ulcerative colitis therapy
- (2021) Jing Zhu et al. Acta Pharmaceutica Sinica B
- Targeting necroptosis in anticancer therapy: mechanisms and modulators
- (2020) Ying Wu et al. Acta Pharmaceutica Sinica B
- Receptor-interacting protein kinase 1 (RIPK1) as a therapeutic target
- (2020) Lauren Mifflin et al. NATURE REVIEWS DRUG DISCOVERY
- Glucocorticoids in Sepsis: To Be or Not to Be
- (2020) Jolien Vandewalle et al. Frontiers in Immunology
- Radiosensitization of human pancreatic cancer by piperlongumine analogues
- (2020) Hao Ma et al. CHINESE CHEMICAL LETTERS
- Identification of the Raf kinase inhibitor TAK‐632 and its analogues as potent inhibitors of necroptosis by targeting RIPK1 and RIPK3
- (2019) Xiaofei Chen et al. BRITISH JOURNAL OF PHARMACOLOGY
- RIP1 inhibition blocks inflammatory diseases but not tumor growth or metastases
- (2019) Snahel Patel et al. CELL DEATH AND DIFFERENTIATION
- N-(7-Cyano-6-(4-fluoro-3-(2-(3-(trifluoromethyl)phenyl)acetamido)phenoxy)benzo[d]thiazol-2-yl)cyclopropanecarboxamide (TAK-632) Analogues as Novel Necroptosis Inhibitors by Targeting Receptor-Interacting Protein Kinase 3 (RIPK3): Synthesis, Structure–Activity Relationships, and in Vivo Efficacy
- (2019) Hao Zhang et al. JOURNAL OF MEDICINAL CHEMISTRY
- Identification of a RIP1 Kinase Inhibitor Clinical Candidate (GSK3145095) for the Treatment of Pancreatic Cancer
- (2019) Philip A. Harris et al. ACS Medicinal Chemistry Letters
- Small-Molecule Inhibitors of Necroptosis: Current Status and Perspectives
- (2019) Chunlin Zhuang et al. JOURNAL OF MEDICINAL CHEMISTRY
- RIP kinase 1–dependent endothelial necroptosis underlies systemic inflammatory response syndrome
- (2018) Matija Zelic et al. JOURNAL OF CLINICAL INVESTIGATION
- Discovery of 7-Oxo-2,4,5,7-tetrahydro-6H-pyrazolo[3,4-c]pyridine Derivatives as Potent, Orally Available, and Brain-Penetrating Receptor Interacting Protein 1 (RIP1) Kinase Inhibitors: Analysis of Structure–Kinetic Relationships
- (2018) Masato Yoshikawa et al. JOURNAL OF MEDICINAL CHEMISTRY
- TBK1 Suppresses RIPK1-Driven Apoptosis and Inflammation during Development and in Aging
- (2018) Daichao Xu et al. CELL
- Necroptosis and RIPK1-mediated neuroinflammation in CNS diseases
- (2018) Junying Yuan et al. NATURE REVIEWS NEUROSCIENCE
- Discovery of a First-in-Class Receptor Interacting Protein 1 (RIP1) Kinase Specific Clinical Candidate (GSK2982772) for the Treatment of Inflammatory Diseases
- (2017) Philip A. Harris et al. JOURNAL OF MEDICINAL CHEMISTRY
- RIPK1 mediates a disease-associated microglial response in Alzheimer’s disease
- (2017) Dimitry Ofengeim et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- DNA-Encoded Library Screening Identifies Benzo[b][1,4]oxazepin-4-ones as Highly Potent and Monoselective Receptor Interacting Protein 1 Kinase Inhibitors
- (2016) Philip A. Harris et al. JOURNAL OF MEDICINAL CHEMISTRY
- Classification of small molecule protein kinase inhibitors based upon the structures of their drug-enzyme complexes
- (2016) Robert Roskoski PHARMACOLOGICAL RESEARCH
- RIPK1 mediates axonal degeneration by promoting inflammation and necroptosis in ALS
- (2016) Yasushi Ito et al. SCIENCE
- Activation of Necroptosis in Multiple Sclerosis
- (2015) Dimitry Ofengeim et al. Cell Reports
- Activity of Protein Kinase RIPK3 Determines Whether Cells Die by Necroptosis or Apoptosis
- (2014) K. Newton et al. SCIENCE
- Interferon-induced RIP1/RIP3-mediated necrosis requires PKR and is licensed by FADD and caspases
- (2013) R. J. Thapa et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- RIP Kinase-Dependent Necrosis Drives Lethal Systemic Inflammatory Response Syndrome
- (2011) Linde Duprez et al. IMMUNITY
- Toll-like receptors activate programmed necrosis in macrophages through a receptor-interacting kinase-3-mediated pathway
- (2011) S. He et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- The Dual Functions of Receptor Interacting Protein 1 in Fas-Induced Hepatocyte Death During Sepsis
- (2011) Sam I. McNeal et al. SHOCK
- Tumor necrosis factor-mediated cell death: to break or to burst, that’s the question
- (2010) Franky Van Herreweghe et al. CELLULAR AND MOLECULAR LIFE SCIENCES
- Circulating mitochondrial DAMPs cause inflammatory responses to injury
- (2010) Qin Zhang et al. NATURE
- Phosphorylation-Driven Assembly of the RIP1-RIP3 Complex Regulates Programmed Necrosis and Virus-Induced Inflammation
- (2009) YoungSik Cho et al. CELL
- Identification of RIP1 kinase as a specific cellular target of necrostatins
- (2008) Alexei Degterev et al. Nature Chemical Biology
Become a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get StartedAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started